EDC/NHS-mediated heparinization of small intestinal submucosa for recombinant adeno-associated virus serotype 2 binding and transduction

Biomaterials

Volumn 28, Issue 14, 2007, Pages 2350-2357

  Yue, Tse Wei ^a   Chien, Wei Che ^a   Tseng, S Ja ^a   Tang, Shiue Cheng ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Adsorption; Fibroblast; Gene expression; Gene transfer; Heparin; SIS

Indexed keywords

FIBROBLAST; GENE EXPRESSION; HEPARIN;

CELL CULTURE; CHROMATOGRAPHY; PROTEINS; TISSUE; VECTORS; VIRUSES;

GENE TRANSFER;

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; BETA GALACTOSIDASE; GREEN FLUORESCENT PROTEIN; N HYDROXYSUCCINIMIDE; PARVOVIRUS VECTOR; RECOMBINANT ADENO ASSOCIATED VIRUS 2 VECTOR; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL CULTURE; CONJUGATION; CONTROLLED STUDY; CROSS LINKING; EMBRYO; GENE EXPRESSION; GENE TARGETING; HEPARINIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMALL INTESTINE MUCOSA; ULTRACENTRIFUGATION;

BETA-GALACTOSIDASE; CARBODIIMIDES; CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CROSS-LINKING REAGENTS; DEPENDOVIRUS; FIBROSARCOMA; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPARIN; HUMANS; INTESTINAL MUCOSA; LUCIFERASES; SEROTYPING; SUCCINIMIDES; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS;

EID: 33847152061     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.01.035     Document Type: Article

References (39)

1. Mizuguchi H., and Hayakawa T. Targeted adenovirus vectors. Hum Gene Ther 15 11 (2004) 1034-1044
2. Ponnazhagan S., Mahendra G., Kumar S., Thompson J.A., and Castillas Jr. M. Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands. J Virol 76 24 (2002) 12900-12907
3. Yun Y.H., Goetz D.J., Yellen P., and Chen W. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 25 1 (2004) 147-157
4. Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Kruger A., et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 9 2 (2002) 102-109
5. Segura T., Chung P.H., and Shea L.D. DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach. Biomaterials 26 13 (2005) 1575-1584
6. Huang Y.C., Riddle K., Rice K.G., and Mooney D.J. Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum Gene Ther 16 5 (2005) 609-617
7. De Laporte L., Cruz Rea J., and Shea L.D. Design of modular non-viral gene therapy vectors. Biomaterials 27 7 (2006) 947-954
8. Stachelek S.J., Song C., Alferiev I., Defelice S., Cui X., Connolly J.M., et al. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants. Gene Ther 11 1 (2004) 15-24
9. Gu D.L., Nguyen T., Gonzalez A.M., Printz M.A., Pierce G.F., Sosnowski B.A., et al. Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. Mol Ther 9 5 (2004) 699-711
10. Bellocq N.C., Kang D.W., Wang X., Jensen G.S., Pun S.H., Schluep T., et al. Synthetic biocompatible cyclodextrin-based constructs for local gene delivery to improve cutaneous wound healing. Bioconjug Chem 15 6 (2004) 1201-1211
11. Koefoed M., Ito H., Gromov K., Reynolds D.G., Awad H.A., Rubery P.T., et al. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther 12 2 (2005) 212-218
12. Ito H., Koefoed M., Tiyapatanaputi P., Gromov K., Goater J.J., Carmouche J., et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 11 3 (2005) 291-297
13. Moss R.B., Rodman D., Spencer L.T., Aitken M.L., Zeitlin P.L., Waltz D., et al. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest 125 2 (2004) 509-521
14. Manno C.S., Arruda V.R., Pierce G.F., Glader B., Ragni M., Rasko J., et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12 3 (2006) 342-347
15. Snyder R.O. Adeno-associated virus-mediated gene delivery. J Gene Med 1 3 (1999) 166-175
16. Summerford C., and Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72 2 (1998) 1438-1445
17. Auricchio A., Hildinger M., O'Connor E., Gao G.P., and Wilson J.M. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther 12 1 (2001) 71-76
18. Brown-Etris M., Cutshall W.D., and Hiles M.C. A new biomaterial derived from small intestine submucosa and developed into a wound matrix device. Wounds 14 4 (2002) 150-166
19. Demling R.H., Niezgoda J.A., Haraway G.D., and Mostow E.N. Small intestinal submucosa wound matrix and full-thickness venous ulcers: preliminary results. Wounds 16 1 (2004) 18-22
20. Mostow E.N., Haraway G.D., Dalsing M., Hodde J.P., and King D. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 41 5 (2005) 837-843
21. Keuren J.F., Wielders S.J., Driessen A., Verhoeven M., Hendriks M., and Lindhout T. Covalently-bound heparin makes collagen thromboresistant. Arterioscler Thromb Vasc Biol 24 3 (2004) 613-617
22. Wissink M.J., Beernink R., Poot A.A., Engbers G.H., Beugeling T., van Aken W.G., et al. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release 64 1-3 (2000) 103-114
23. Wissink M.J., Beernink R., Pieper J.S., Poot A.A., Engbers G.H., Beugeling T., et al. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. Biomaterials 22 2 (2001) 151-163
24. Wissink M.J., Beernink R., Pieper J.S., Poot A.A., Engbers G.H., Beugeling T., et al. Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials 22 16 (2001) 2291-2299
25. Yao C., Prevel P., Koch S., Schenck P., Noah E.M., Pallua N., et al. Modification of collagen matrices for enhancing angiogenesis. Cells Tissues Organs 178 4 (2004) 189-196
26. Yao C., Roderfeld M., Rath T., Roeb E., Bernhagen J., and Steffens G. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices. Biomaterials 27 8 (2006) 1608-1616
27. Tang S.C., Sambanis A., and Sibley E. Proteasome modulating agents induce rAAV2-mediated transgene expression in human intestinal epithelial cells. Biochem Biophys Res Commun 331 4 (2005) 1392-1400
28. Tang S.C., and Sambanis A. Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer. Biochem Biophys Res Commun 303 2 (2003) 645-652
29. Qing K., Mah C., Hansen J., Zhou S., Dwarki V., and Srivastava A. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 5 1 (1999) 71-77
30. Hurst R.E., and Bonner R.B. Mapping of the distribution of significant proteins and proteoglycans in small intestinal submucosa by fluorescence microscopy. J Biomater Sci Polym Ed 12 11 (2001) 1267-1279
31. Hodde J. Naturally occurring scaffolds for soft tissue repair and regeneration. Tissue Eng 8 2 (2002) 295-308
32. Kini S., Gagner M., de Csepel J., Gentileschi P., and Dakin G. A biodegradeable membrane from porcine intestinal submucosa to reinforce the gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass: preliminary report. Obes Surg 11 4 (2001) 469-473
33. Ueno T., Pickett L.C., de la Fuente S.G., Lawson D.C., and Pappas T.N. Clinical application of porcine small intestinal submucosa in the management of infected or potentially contaminated abdominal defects. J Gastrointest Surg 8 1 (2004) 109-112
34. Colvert III J.R., Kropp B.P., Cheng E.Y., Pope J.C.t., Brock III J.W., Adams M.C., et al. The use of small intestinal submucosa as an off-the-shelf urethral sling material for pediatric urinary incontinence. J Urol 168 4 Pt 2 (2002) 1872-1875 [discussion 1875-1876]
35. Baum C., Kustikova O., Modlich U., Li Z., and Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 17 3 (2006) 253-263
36. Compton T., Nowlin D.M., and Cooper N.R. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193 2 (1993) 834-841
37. Pajusola K., Gruchala M., Joch H., Luscher T.F., Yla-Herttuala S., and Bueler H. Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells. J Virol 76 22 (2002) 11530-11540
38. Duffy A.M., O'Doherty A.M., O'Brien T., and Strappe P.M. Purification of adenovirus and adeno-associated virus: comparison of novel membrane-based technology to conventional techniques. Gene Ther 12 Suppl 1 (2005) S62-S72
39. Brument N., Morenweiser R., Blouin V., Toublanc E., Raimbaud I., Cherel Y., et al. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. Mol Ther 6 5 (2002) 678-686